Alloreactive cytotoxic T cells recognize minor transplantation antigens presented by major histocompatibility complex class Ib molecules

Daniel E. Speiser, Martin F. Bachmann, Mark J. Soloski, James Forman, Pamela S. Ohashi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background. Cytotoxic T lymphocytes (CTLs) contribute to the rejection of transplanted tissues through two pathways: first, by direct recognition of foreign graft major histocompatibility complex (MHC) class I molecules; and second, by recognition of foreign graft-derived peptides presented by classical MHC class Ia molecules that are matched between graft and donor. However, a number of observations suggest that additional categories of CTL recognition patterns may exist, but they remain to be defined molecularly. Methods. Previous studies showed that the murine nonclassical MHC molecule H2 M3 may be involved in allorecognition. We investigated whether other members of nonclassical MHC class Ib, namely Qa1 and Qa2, may be recognized. Alloreactive CTLs were generated from mice mismatched for non-MHC and/or MHC genetic backgrounds and tested using various target cells, including cells transfected with Qa1 or Qa2. Furthermore, candidate peptides were synthesized and used to generate CTLs specific for peptide presented by Qa1 or Qa2. Results. The experiments demonstrate that allogeneic and xenogeneic peptides were recognized by CTLs when presented on shared nonclassical MHC class Ib Qa1 and Qa2 molecules. Conclusions. The results confirm that MHC class Ib molecules present peptides to CTLs. This potentially important alloreactivity pathway may be functional between most individuals because sharing of MHC class Ib alleles is frequent.

Original languageEnglish (US)
Pages (from-to)646-650
Number of pages5
JournalTransplantation
Volume66
Issue number5
DOIs
StatePublished - Sep 15 1998

Fingerprint

Histocompatibility Antigens
Major Histocompatibility Complex
Cytotoxic T-Lymphocytes
T-Lymphocytes
Peptides
Transplants
Alleles

ASJC Scopus subject areas

  • Transplantation

Cite this

Alloreactive cytotoxic T cells recognize minor transplantation antigens presented by major histocompatibility complex class Ib molecules. / Speiser, Daniel E.; Bachmann, Martin F.; Soloski, Mark J.; Forman, James; Ohashi, Pamela S.

In: Transplantation, Vol. 66, No. 5, 15.09.1998, p. 646-650.

Research output: Contribution to journalArticle

Speiser, Daniel E. ; Bachmann, Martin F. ; Soloski, Mark J. ; Forman, James ; Ohashi, Pamela S. / Alloreactive cytotoxic T cells recognize minor transplantation antigens presented by major histocompatibility complex class Ib molecules. In: Transplantation. 1998 ; Vol. 66, No. 5. pp. 646-650.
@article{95a91434eacd4c74a0ade0ab5dc11890,
title = "Alloreactive cytotoxic T cells recognize minor transplantation antigens presented by major histocompatibility complex class Ib molecules",
abstract = "Background. Cytotoxic T lymphocytes (CTLs) contribute to the rejection of transplanted tissues through two pathways: first, by direct recognition of foreign graft major histocompatibility complex (MHC) class I molecules; and second, by recognition of foreign graft-derived peptides presented by classical MHC class Ia molecules that are matched between graft and donor. However, a number of observations suggest that additional categories of CTL recognition patterns may exist, but they remain to be defined molecularly. Methods. Previous studies showed that the murine nonclassical MHC molecule H2 M3 may be involved in allorecognition. We investigated whether other members of nonclassical MHC class Ib, namely Qa1 and Qa2, may be recognized. Alloreactive CTLs were generated from mice mismatched for non-MHC and/or MHC genetic backgrounds and tested using various target cells, including cells transfected with Qa1 or Qa2. Furthermore, candidate peptides were synthesized and used to generate CTLs specific for peptide presented by Qa1 or Qa2. Results. The experiments demonstrate that allogeneic and xenogeneic peptides were recognized by CTLs when presented on shared nonclassical MHC class Ib Qa1 and Qa2 molecules. Conclusions. The results confirm that MHC class Ib molecules present peptides to CTLs. This potentially important alloreactivity pathway may be functional between most individuals because sharing of MHC class Ib alleles is frequent.",
author = "Speiser, {Daniel E.} and Bachmann, {Martin F.} and Soloski, {Mark J.} and James Forman and Ohashi, {Pamela S.}",
year = "1998",
month = "9",
day = "15",
doi = "10.1097/00007890-199809150-00017",
language = "English (US)",
volume = "66",
pages = "646--650",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Alloreactive cytotoxic T cells recognize minor transplantation antigens presented by major histocompatibility complex class Ib molecules

AU - Speiser, Daniel E.

AU - Bachmann, Martin F.

AU - Soloski, Mark J.

AU - Forman, James

AU - Ohashi, Pamela S.

PY - 1998/9/15

Y1 - 1998/9/15

N2 - Background. Cytotoxic T lymphocytes (CTLs) contribute to the rejection of transplanted tissues through two pathways: first, by direct recognition of foreign graft major histocompatibility complex (MHC) class I molecules; and second, by recognition of foreign graft-derived peptides presented by classical MHC class Ia molecules that are matched between graft and donor. However, a number of observations suggest that additional categories of CTL recognition patterns may exist, but they remain to be defined molecularly. Methods. Previous studies showed that the murine nonclassical MHC molecule H2 M3 may be involved in allorecognition. We investigated whether other members of nonclassical MHC class Ib, namely Qa1 and Qa2, may be recognized. Alloreactive CTLs were generated from mice mismatched for non-MHC and/or MHC genetic backgrounds and tested using various target cells, including cells transfected with Qa1 or Qa2. Furthermore, candidate peptides were synthesized and used to generate CTLs specific for peptide presented by Qa1 or Qa2. Results. The experiments demonstrate that allogeneic and xenogeneic peptides were recognized by CTLs when presented on shared nonclassical MHC class Ib Qa1 and Qa2 molecules. Conclusions. The results confirm that MHC class Ib molecules present peptides to CTLs. This potentially important alloreactivity pathway may be functional between most individuals because sharing of MHC class Ib alleles is frequent.

AB - Background. Cytotoxic T lymphocytes (CTLs) contribute to the rejection of transplanted tissues through two pathways: first, by direct recognition of foreign graft major histocompatibility complex (MHC) class I molecules; and second, by recognition of foreign graft-derived peptides presented by classical MHC class Ia molecules that are matched between graft and donor. However, a number of observations suggest that additional categories of CTL recognition patterns may exist, but they remain to be defined molecularly. Methods. Previous studies showed that the murine nonclassical MHC molecule H2 M3 may be involved in allorecognition. We investigated whether other members of nonclassical MHC class Ib, namely Qa1 and Qa2, may be recognized. Alloreactive CTLs were generated from mice mismatched for non-MHC and/or MHC genetic backgrounds and tested using various target cells, including cells transfected with Qa1 or Qa2. Furthermore, candidate peptides were synthesized and used to generate CTLs specific for peptide presented by Qa1 or Qa2. Results. The experiments demonstrate that allogeneic and xenogeneic peptides were recognized by CTLs when presented on shared nonclassical MHC class Ib Qa1 and Qa2 molecules. Conclusions. The results confirm that MHC class Ib molecules present peptides to CTLs. This potentially important alloreactivity pathway may be functional between most individuals because sharing of MHC class Ib alleles is frequent.

UR - http://www.scopus.com/inward/record.url?scp=0032530715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032530715&partnerID=8YFLogxK

U2 - 10.1097/00007890-199809150-00017

DO - 10.1097/00007890-199809150-00017

M3 - Article

VL - 66

SP - 646

EP - 650

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -